Latest news
Insider Selling: Axsome Therapeutics (NASDAQ:AXSM) CEO Sells $9,541,298.04 in Stock - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:41 GMTAxsome Therapeutics (NASDAQ:AXSM) CEO Herriot Tabuteau Sells 4,660 Shares - MarketBeatMarketBeat · Fri, 07 Aug 2026 23:12:40 GMTEmpowered Funds LLC Grows Stake in Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Tue, 04 Aug 2026 08:44:01 GMTMizuho Issues Pessimistic Forecast for Axsome Therapeutics (NASDAQ:AXSM) Stock Price - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMTRenaissance Technologies LLC Sells 5,700 Shares of Axsome Therapeutics, Inc. $AXSM - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMT